NextGen 2024: Monitoring &Treating Lung Disease in SJIA Session Part 1
NextGen 2024: Monitoring &Treating Lung Disease in SJIA Session Part 1
Presentation from Dr. Claudia Bracaglia: Monitoring and Treating Lung Disease in Still's Disease
NextGen 2024: Monitoring &Treating Lung Disease in SJIA Session Part 1
@SJIA_Foundation2 months ago
Lung Disease in Still's Disease

Monitoring & Treating Lung Disease in Still's Disease
Claudia Bracaglia Division of Rheumatology Ospedale Pediatrico Bambino Gesù Roma - Italy claudia.bracaglia@opbg.net

- *2 pts were already on cyclosporine before LD diagnosis
- **3 pts switched from cyclosporine to MMF after LD diagnosis
- *2 pts were already on cyclosporine before LD diagnosis
- **3 pts switched from cyclosporine to MMF after LD diagnosis
- -1 pt improved with IL-1i and MMF
- -2 pts improved with MAS825
- -1 pt stable with emapalumab
- -1 pt worsened despite MAS825 and she now on emapalumab
- -1 pt developed LD on sirolimus
- -No pt developed LD complication
- -No pt died

61 SD-LD patients from 21 Ped Rheum Centres European Registry on SD associated LD





European Registry on sJIA associated LD
61 SJIA-LD patients from 21 Ped Rheum Centres





SD associated LD Bambino Gesù experience


SD associated LD Bambino Gesù experience

*The reaction occurred after the first and the third administration of TCZ in 1 pt. LD developed before the drug reaction in 2 pts.

SD associated LD Bambino Gesù experience


SD associated LD Bambino Gesù experience

Outcome

1/7

2/7

3/7

4/7

5/7

6/7

7/7
Related Jaunts

Current treatments in macrophage activation syndrome - METAPHOR projec
@rashmi
3 months ago •
710 views

NextGen 2024: Unmet Needs & Clinical Trial Challenges Session Part 2
@SJIA_Foundation
2 months ago •
194 views

NextGen 2024: Weaning meds when disease is controlled Session Part 2
@SJIA_Foundation
2 months ago •
294 views

NextGen 2024: Unmet Needs & Clinical Trial Challenges Session Part 1
@SJIA_Foundation
2 months ago •
193 views

NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 1
@SJIA_Foundation
2 months ago •
458 views

NextGen 2024: Weaning meds when disease is controlled Session Part 1
@SJIA_Foundation
2 months ago •
211 views

NextGen 2024: Monitoring &Treating Lung Disease in SJIA Session Part 2
@SJIA_Foundation
2 months ago •
227 views
More from author

NextGen 2024: Weaning meds when disease is controlled Session Part 2
@SJIA_Foundation
2 months ago •
294 views

NextGen 2024: Weaning meds when disease is controlled Session Part 1
@SJIA_Foundation
2 months ago •
211 views

NextGen 2024: Monitoring &Treating Lung Disease in SJIA Session Part 2
@SJIA_Foundation
2 months ago •
227 views

NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 5
@SJIA_Foundation
2 months ago •
180 views

NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 4
@SJIA_Foundation
2 months ago •
189 views

NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 3
@SJIA_Foundation
2 months ago •
183 views

NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 2
@SJIA_Foundation
2 months ago •
189 views

NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 1
@SJIA_Foundation
2 months ago •
458 views